ROBTVOne of the analysts (Shameez Rampersaad [sp?]) on Michael Vaughn Live last nite (Nov 1; it's available on the ROBTV website) responded to a call about BNC. The analyst said that thing that keeps BNC down is that it keeps missing its target for the commercialization of the E. coli vaccine. He said that it still has not been even determined if the US Dept of Agriculture or US FDA will have jurisdiction in the states over approval and it could be a while coming (maybe a couple years away) even though the vaccine seems to be working. Does anyone know if BNC elaborates on this US issue in its press releases or website?